Oxycodone on Packaging Line Leads to Recall of Betaxolol
Betaxolol may cause a slowing in the heart rate in some patients; an opioid could increase the effect.
KVK-Tech is voluntarily recalling one lot of Betaxolol Tablets, USP 10 mg, which is a beta blocker used to treat patients with hypertension and also used to treat glaucoma. The company is making the recall as a precautionary measure after one tablet Oxycodone HCl tablet 5 mg was found on the packaging line of Betaxolol.
KVK has not received any reports of foreign tablet in any bottle of Betaxolol.
Betaxolol has a warning on its label about the possibility of a slowing in the heart rate in elderly patients. This effect could be increased by inadvertent opioid administration. Additionally, some patients prescribed low-dose betaxolol might be have compromised heart and lung function that is also likely to be exacerbated by an opioid, the company said.
The affected Betaxolol has a lot number of 17853A and has an expiration date of June 2027. The batch was distributed nationwide to wholesalers and retailers.
FDA Approves Subcutaneous Tecentriq to Treat Multiple Cancers
September 13th 2024Tecentriq Hybreza can be administered over seven minutes, compared with 30 to 60 minutes for IV infusion of Tecentriq. There is no word yet on when Tecentriq Hybreza will be available or what the price will be.
Read More
FDA Warns of Liver Injury with Veozah for Hot Flashes
September 12th 2024The FDA has identified a probable case of serious drug induced liver injury that occurred in a woman in the United States who had received Veozah. The agency is requiring additional liver blood testing after starting therapy.
Read More
